DGAP-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Strategic Company Decision/Miscellaneous 
Eckert & Ziegler Receives Technetium Generator Licenses for Brazil 
12-Apr-2021 / 21:12 CET/CEST 
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a 
service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Sao Paulo, 12 April 2021 - The Brazilian regulator ANVISA has provided Eckert & Ziegler Brasil Comercial Ltda., a fully 
owned subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), with a license to 
import and distribute technetium generators. This is the second license ever given to an organization in Brazil, and 
only the first one for a private company. Technetium generators are a core component for a nuclear imaging procedure 
called SPECT, which is used for the detection of medical abnormalities. In Brazil, the SPECT market has a volume of 
about 100 mm Euro annually. Eckert & Ziegler already services about 500 hospitals and clinics in this country with 
medical devices and radioisotopes, and hopes to start shipping SPECT products in the third quarter of 2021. 
Contact: 
Eckert & Ziegler AG, Karolin Riehle, Investor Relations 
Robert-Rössle-Str. 10, 13125 Berlin, Germany 
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com 
=---------------------------------------------------------------------------------------------------------------------- 
Information and Explanation of the Issuer to this News: 
Claudia Goulart, CEO of Eckert & Ziegler Brasil, commented: 'We are very excited that Eckert & Ziegler has now been 
given the opportunity to service the Brazilian nuclear medicine community with SPECT products. It compliments perfectly 
our existing portfolio of radiopharmaceuticals, among them Lu-177 and O-18, and the services we provide for 
international pharmaceutical companies'. 
=---------------------------------------------------------------------------------------------------------------------- 
12-Apr-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and 
Press Releases. 
Archive at www.dgap.de 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      Eckert & Ziegler Strahlen- und Medizintechnik AG 
              Robert-Rössle-Str.10 
              13125 Berlin 
              Germany 
Phone:        +49 30 941084-138 
Fax:          +49 30 941084-112 
E-mail:       karolin.riehle@ezag.de 
Internet:     www.ezag.de 
ISIN:         DE0005659700 
WKN:          565970 
Indices:      SDAX 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, 
              Hamburg, Munich, Stuttgart, Tradegate Exchange 
EQS News ID:  1183796 
 
End of Announcement  DGAP News Service 
=------------

1183796 12-Apr-2021 CET/CEST

(END) Dow Jones Newswires

April 12, 2021 15:13 ET (19:13 GMT)